Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials.

Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials. Am Heart J. 2021 07; 237:45-53.

View in: PubMed

subject areas

Aged
Biomarkers
Female
Heart Failure
Humans
Male
Middle Aged
Natriuretic Peptides
Prognosis
Risk Assessment
Risk Factors
Stroke Volume

authors with profiles

Michael R. Zile